These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37187232)

  • 1. Prediction of Kv11.1 potassium channel PAS-domain variants trafficking via machine learning.
    Immadisetty K; Fang X; Ramon GS; Hartle CM; McCoy TP; Center RG; Mirshahi T; Delisle BP; Kekenes-Huskey PM
    J Mol Cell Cardiol; 2023 Jul; 180():69-83. PubMed ID: 37187232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and clinical characterization of a novel homozygous KCNH2 missense variant in the pore region of Kv11.1 leading to a viable but severe long-QT syndrome.
    Delinière A; Jaupart L; Janin A; Millat G; Boulin T; Andrini O; Chevalier P
    Gene; 2024 Mar; 897():148076. PubMed ID: 38086455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation-Specific Differences in Kv7.1 (
    Kekenes-Huskey PM; Burgess DE; Sun B; Bartos DC; Rozmus ER; Anderson CL; January CT; Eckhardt LL; Delisle BP
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel intracellular transport-refractory mutations in KCNH2 identified in patients with symptomatic long QT syndrome.
    Fukumoto D; Ding WG; Wada Y; Fujii Y; Ichikawa M; Takayama K; Fukuyama M; Kato K; Itoh H; Makiyama T; Omatsu-Kanbe M; Matsuura H; Horie M; Ohno S
    J Cardiol; 2018 Apr; 71(4):401-408. PubMed ID: 29146210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.
    Cordeiro JM; Perez GJ; Schmitt N; Pfeiffer R; Nesterenko VV; Burashnikov E; Veltmann C; Borggrefe M; Wolpert C; Schimpf R; Antzelevitch C
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1181-90. PubMed ID: 21164565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Invalidation of Putative Sudden Infant Death Syndrome-Associated Variants in the
    Smith JL; Tester DJ; Hall AR; Burgess DE; Hsu CC; Elayi SC; Anderson CL; January CT; Luo JZ; Hartzel DN; Mirshahi UL; Murray MF; Mirshahi T; Ackerman MJ; Delisle BP
    Circ Arrhythm Electrophysiol; 2018 May; 11(5):e005859. PubMed ID: 29752375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteostasis interactomes of trafficking-deficient variants of the voltage-gated potassium channel K
    Egly CL; Barny LA; Do T; McDonald EF; Knollmann BC; Plate L
    J Biol Chem; 2024 Jul; 300(7):107465. PubMed ID: 38876300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel K
    Kozek KA; Glazer AM; Ng CA; Blackwell D; Egly CL; Vanags LR; Blair M; Mitchell D; Matreyek KA; Fowler DM; Knollmann BC; Vandenberg JI; Roden DM; Kroncke BM
    Heart Rhythm; 2020 Dec; 17(12):2180-2189. PubMed ID: 32522694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2
    Ono M; Burgess DE; Schroder EA; Elayi CS; Anderson CL; January CT; Sun B; Immadisetty K; Kekenes-Huskey PM; Delisle BP
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32759882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction.
    Biliczki P; Girmatsion Z; Brandes RP; Harenkamp S; Pitard B; Charpentier F; Hébert TE; Hohnloser SH; Baró I; Nattel S; Ehrlich JR
    Heart Rhythm; 2009 Dec; 6(12):1792-801. PubMed ID: 19959132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
    Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
    Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of functional ion-channel abnormalities in a consecutive Long QT cohort with novel missense genetic variants of unknown significance.
    Steffensen AB; Refaat MM; David JP; Mujezinovic A; Calloe K; Wojciak J; Nussbaum RL; Scheinman MM; Schmitt N
    Sci Rep; 2015 Jun; 5():10009. PubMed ID: 26066609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome sequencing in a genetically elusive multigenerational long QT syndrome pedigree identifies a novel LQT2-causative deeply intronic KCNH2 variant.
    Tobert KE; Tester DJ; Zhou W; Haglund-Turnquist CM; Giudicessi JR; Ackerman MJ
    Heart Rhythm; 2022 Jun; 19(6):998-1007. PubMed ID: 35144019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long QT syndrome-associated mutations in intrauterine fetal death.
    Crotti L; Tester DJ; White WM; Bartos DC; Insolia R; Besana A; Kunic JD; Will ML; Velasco EJ; Bair JJ; Ghidoni A; Cetin I; Van Dyke DL; Wick MJ; Brost B; Delisle BP; Facchinetti F; George AL; Schwartz PJ; Ackerman MJ
    JAMA; 2013 Apr; 309(14):1473-82. PubMed ID: 23571586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.
    McBride CM; Smith AM; Smith JL; Reloj AR; Velasco EJ; Powell J; Elayi CS; Bartos DC; Burgess DE; Delisle BP
    J Membr Biol; 2013 May; 246(5):355-64. PubMed ID: 23546015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A High-Throughput Screening Assay to Identify Drugs that Can Treat Long QT Syndrome Caused by Trafficking-Deficient K
    Egly CL; Blackwell DJ; Schmeckpeper J; Delisle BP; Weaver CD; Knollmann BC
    Mol Pharmacol; 2022 Apr; 101(4):236-245. PubMed ID: 35125346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.
    Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK
    BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
    Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
    PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of loss of Kv11.1 K+ current in mutant T421M-Kv11.1-expressing rat ventricular myocytes: interaction of trafficking and gating.
    Balijepalli SY; Lim E; Concannon SP; Chew CL; Holzem KE; Tester DJ; Ackerman MJ; Delisle BP; Balijepalli RC; January CT
    Circulation; 2012 Dec; 126(24):2809-18. PubMed ID: 23136156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.